Literature DB >> 24379187

Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.

Xiaoliang Jiang1, Prasad Konkalmatt, Yu Yang, John Gildea, John E Jones, Santiago Cuevas, Robin A Felder, Pedro A Jose, Ines Armando.   

Abstract

The dopamine D2 receptor (D2R) negatively regulates inflammation in mouse renal proximal tubule cells (RPTCs), and lack or downregulation of the receptor in mice increases the vulnerability to renal inflammation independent of blood pressure. Some common single-nucleotide polymorphisms (SNPs; rs6276, rs6277, and rs1800497) in the human DRD2 gene are associated with decreased D2R expression and function, as well as high blood pressure. We tested the hypothesis that human RPTCs (hRPTCs) expressing these SNPs have increased expression of inflammatory and injury markers. We studied immortalized hRPTCs carrying D2R SNPs and compared them with cells carrying no D2R SNPs. RPTCs with D2R SNPs had decreased D2R expression and function. The expressions of the proinflammatory tumor necrosis factor-α and the profibrotic transforming growth factor-β1 and its signaling targets Smad3 and Snail1 were increased in hRPTC with D2R SNPs. These cells also showed induction of epithelial mesenchymal transition and production of extracellular matrix proteins, assessed by increased vimentin, fibronectin 1, and collagen I a1. To test the specificity of these D2R SNP effects, hRPTC with D2R SNPs were transfected with a plasmid encoding wild-type DRD2. The expression of D2R was increased and that of transforming growth factor-β1, Smad3, Snail1, vimentin, fibronectin 1, and collagen I a1 was decreased in hRPTC with D2R SNPs transfected with wild-type DRD2 compared with hRPTC-D2R SNP transfected with empty vector. These data support the hypothesis that D2R function has protective effects in hRPTCs and suggest that carriers of these SNPs may be prone to chronic renal disease and high blood pressure.

Entities:  

Keywords:  chronic kidney disease; kidney; receptors, dopamine D2

Mesh:

Substances:

Year:  2013        PMID: 24379187      PMCID: PMC3929206          DOI: 10.1161/HYPERTENSIONAHA.113.02569

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

1.  Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

Authors:  Ming-Zhi Zhang; Bing Yao; Suwan Wang; Xiaofeng Fan; Guanqing Wu; Haichun Yang; Huiyong Yin; Shilin Yang; Raymond C Harris
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

Review 2.  Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders.

Authors:  Amy J McKnight; Diane Currie; Alexander P Maxwell
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

3.  Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.

Authors:  Ronald C W Ma; Claudia H T Tam; Ying Wang; Andrea O Luk; Cheng Hu; Xilin Yang; Vincent Lam; Alfred W H Chan; Janice S K Ho; Chun-Chung Chow; Peter C Y Tong; Weiping Jia; Maggie C Y Ng; Wing-Yee So; Juliana C N Chan
Journal:  JAMA       Date:  2010-08-25       Impact factor: 56.272

Review 4.  Inflammation, immunity, and hypertension.

Authors:  David G Harrison; Tomasz J Guzik; Heinrich E Lob; Meena S Madhur; Paul J Marvar; Salim R Thabet; Antony Vinh; Cornelia M Weyand
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

5.  Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells.

Authors:  Xia Guo; Pedro A Jose; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-09       Impact factor: 4.249

Review 6.  Integrating human and rodent data to identify the genetic factors involved in chronic kidney disease.

Authors:  Michael R Garrett; Marcus G Pezzolesi; Ron Korstanje
Journal:  J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 10.121

Review 7.  Mechanisms of kidney fibrosis and the role of antifibrotic therapies.

Authors:  Leo Deelman; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

8.  RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells.

Authors:  Wen-Yan Huang; Zu-Guo Li; Horea Rus; Xiaoyan Wang; Pedro A Jose; Shi-You Chen
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

9.  Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis.

Authors:  Yingjian Li; Xiaoyue Tan; Chunsun Dai; Donna B Stolz; Dan Wang; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 10.121

10.  ALFRED: an allele frequency resource for research and teaching.

Authors:  Haseena Rajeevan; Usha Soundararajan; Judith R Kidd; Andrew J Pakstis; Kenneth K Kidd
Journal:  Nucleic Acids Res       Date:  2011-10-28       Impact factor: 16.971

View more
  19 in total

1.  Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure.

Authors:  Prasad R Konkalmatt; Laureano D Asico; Yanrong Zhang; Yu Yang; Cinthia Drachenberg; Xiaoxu Zheng; Fei Han; Pedro A Jose; Ines Armando
Journal:  JCI Insight       Date:  2016-06-02

2.  Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.

Authors:  Yanrong Zhang; Xiaoliang Jiang; Chuan Qin; Santiago Cuevas; Pedro A Jose; Ines Armando
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

Review 3.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Authors:  Ines Armando; Prasad Konkalmatt; Robin A Felder; Pedro A Jose
Journal:  Transl Res       Date:  2014-07-25       Impact factor: 7.012

Review 4.  Antihypertensive mechanisms of intra-renal dopamine.

Authors:  Ming-Zhi Zhang; Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

5.  MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells.

Authors:  Fei Han; Prasad Konkalmatt; Jianghua Chen; John Gildea; Robin A Felder; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2015-03-23       Impact factor: 10.190

6.  Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.

Authors:  Zhen Wang; Weiwei Guan; Yu Han; Hongmei Ren; Xiaofeng Tang; Hui Zhang; Yukai Liu; Jinjuan Fu; Duofen He; Laureano D Asico; Pedro A Jose; Lin Zhou; Liyong Chen; Chunyu Zeng
Journal:  Transplantation       Date:  2015-11       Impact factor: 4.939

Review 7.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

8.  The long noncoding RNA landscape in hypoxic and inflammatory renal epithelial injury.

Authors:  Jennie Lin; Xuan Zhang; Chenyi Xue; Hanrui Zhang; Michael G S Shashaty; Sager J Gosai; Nuala Meyer; Alison Grazioli; Christine Hinkle; Jennifer Caughey; Wenjun Li; Katalin Susztak; Brian D Gregory; Mingyao Li; Muredach P Reilly
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-23

9.  Sodium-hydrogen exchanger regulatory factor-1 (NHERF1) confers salt sensitivity in both male and female models of hypertension in aging.

Authors:  Sathnur Pushpakumar; Asrar Ahmad; Corey J Ketchem; Pedro A Jose; Edward J Weinman; Utpal Sen; Eleanor D Lederer; Syed J Khundmiri
Journal:  Life Sci       Date:  2020-01-03       Impact factor: 5.037

Review 10.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.